Market revenue in 2023 | USD 147.0 million |
Market revenue in 2030 | USD 216.1 million |
Growth rate | 5.7% (CAGR from 2023 to 2030) |
Largest segment | Coronary stents |
Fastest growing segment | Accessory Devices |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Intravascular Imaging Catheters and Pressure Guidewires, Coronary Stents, PTCA Balloon Catheters, Accessory Devices |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Koninklijke Philips NV, Cardinal Health Inc, Terumo Corp, Teleflex Inc, B. Braun, Biosensors, BIOTRONIK, Asahi Intecc Co Ltd, Cook Medical, Merit Medical Systems Inc, Haemonetics Corp, Vascular Solutions, Zeon Corp, Alvimedica, Meril Life, Medinol |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to interventional cardiology devices market will help companies and investors design strategic landscapes.
Coronary stents was the largest segment with a revenue share of 51.02% in 2023. Horizon Databook has segmented the Brazil interventional cardiology devices market based on intravascular imaging catheters and pressure guidewires, coronary stents, ptca balloon catheters, accessory devices covering the revenue growth of each sub-segment from 2018 to 2030.
The interventional cardiology devices market in Brazil has shown robust growth in recent years, driven by increasing prevalence of CVDs and advancements in medical technology. With growing focus on R&D within the country, Brazil is expected to become a significant contributor to innovation in this sector.
Local initiatives aimed at fostering research collaborations and improving infrastructure are expected to further fuel the expansion of the interventional cardiology devices market in Brazil. Interventional cardiology devices in Brazil are regulated by the National Health Surveillance Agency (ANVISA).
This agency mandates rigorous evaluations for safety & efficacy through premarket approvals and postmarket surveillance. Compliance with ANVISA regulations is imperative for manufacturers to access the Brazilian market, ensuring patient safety and product quality.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil interventional cardiology devices market , including forecasts for subscribers. This country databook contains high-level insights into Brazil interventional cardiology devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account